Population pharmacokinetics of ondansetron: a covariate analysis

Por de Alwis, D P, Aarons, L, Palmer, J L
Publicado em 1998

Implementation of Quantitative and Systems Pharmacology in Large Pharma

Por Visser, S A G, de Alwis, D P, Kerbusch, T, Stone, J A, Allerheiligen, S R B
Publicado no CPT Pharmacometrics Syst Pharmacol (2014)

Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic

Por Kang, S. P., Gergich, K., Lubiniecki, G. M., de Alwis, D. P., Chen, C., Tice, M. A. B., Rubin, E. H.
Publicado no Ann Oncol (2017)

Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer

Por Chatterjee, M., Turner, D. C., Felip, E., Lena, H., Cappuzzo, F., Horn, L., Garon, E. B., Hui, R., Arkenau, H.-T., Gubens, M. A., Hellmann, M. D., Dong, D., Li, C., Mayawala, K., Freshwater, T., Ahamadi, M., Stone, J., Lubiniecki, G. M., Zhang, J., Im, E., De Alwis, D. P., Kondic, A. G., Fløtten, Ø.
Publicado no Ann Oncol (2016)